Depression in people with alopecia areata
Part of Mental health, Skin clinical trials.
This study looks at how common depression is in people who have alopecia areata (a condition that causes patchy hair loss). It aims to understand the emotional impact of the condition, which may help doctors provide better support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with alopecia areata (patchy hair loss).
- You are 18 years old or older.
- You are willing to take part and sign a consent form.
- Your hair loss is not caused by another medical condition.
- You did not have a diagnosed mental health condition (like depression) before your alopecia areata started.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks the safety and effectiveness of alopecia areata treatments in teenagers aged 12-17. It helps doctors understand which treatments work best and are safest for young people with severe hair loss.
This trial tests a new topical cream for people with patchy alopecia areata (a type of hair loss). It aims to help regrow hair without using stronger medicines.
This registry collects information from adults with alopecia areata who are starting or taking certain approved medications. It helps researchers understand how well these treatments work and how safe they are in real-world care.
This trial tests an experimental tablet for teenagers with severe alopecia areata, a condition causing patchy hair loss. The treatment may help regrow hair with clearer information about safety and effectiveness.
This study tests whether a new drug called LY4005130 can help regrow hair in adults with severe alopecia areata (an autoimmune condition causing patchy or widespread hair loss). The trial is looking for people who have lost a significant amount of hair and haven't seen it grow back on its own for at least 6 months.
This study tests if upadacitinib can help young people with severe alopecia areata (a condition causing patchy hair loss) regrow their hair. It may be an option if hair loss has been present for less than 8 years and there has been no recent improvement.
Hear when a new Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.